Shenzhen Institute for Drug Control

Shenzhen, China · 1 patent family

Shenzhen Institute for Drug Control (Shenzhen, China): 1 patent family in the de novo peptide sequencing catalog.

Patents (1)

  • CN117607307A A method and its application for de novo sequencing of monoclonal antibodies ↗ (Shenzhen Institute for Drug Control, priority 2023-12-06, granted)

Patent families this institution was the original assignee of.

Seen in the charts

Back to the full map

Back to top